Hepatoprotective Role of Carvedilol against Ischemic Hepatitis Associated with Acute Heart Failure via Targeting miRNA-17 and Mitochondrial Dynamics-Related Proteins: An In Vivo and In Silico Study

DI Mohamed, SF Ezzat, WM Elayat, OA El-Kharashi, HF Abd El-Kareem, HHA Nahas, BA Abdel-Wahab, SZ Alshawwa, A Saleh, YA Helmy, E Khairy, EM Saied

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
Article number832
Number of pages31
JournalPharmaceuticals
Volume15
Issue number7
DOIs
StatePublished - Jul 2022

Funding

Funding: This research was funded by Faculty of Medicine, and Faculty of Science, Ain Shams University, Egypt. This research was also funded by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2022R141), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Keywords

  • DNM1L
  • MAPK
  • PGC-1 alpha
  • Acute heart failure
  • Carvedilol
  • Histopathology
  • Ischemic hepatitis
  • MiRNA-17
  • Mitofusin 2
  • Molecular modelling
  • Oxidative stress

Fingerprint

Dive into the research topics of 'Hepatoprotective Role of Carvedilol against Ischemic Hepatitis Associated with Acute Heart Failure via Targeting miRNA-17 and Mitochondrial Dynamics-Related Proteins: An In Vivo and In Silico Study'. Together they form a unique fingerprint.

Cite this